Life sciences seen as key at SPIE Photonics West '14
Again and again at SPIE Photonics West 2014 (February 1–6), I found evidence of the importance of life sciences applications among optics and photonics suppliers and systems developers. Despite setbacks imposed by the U.S. government's "sequester" of 2013, biophotonics companies are optimistic and see opportunity. This was evident across the exhibit hall at both the BiOS and Photonics West expos. A good example is the fact that Texas Instruments (TI; Dallas, TX) has identified biomedicine as a key application domain for its DLP technology, which it says can reduce size and cost for biospectroscopy and improve accuracy ...
Login to comment.